Finance

Lists
ALKEM:NSE
Alkem Laboratories Ltd
5 310,00 INR
-0,76%
(-40,50) 1D
8-окт., 12:17:50 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALKEM...
Open
5 407,00 INR
High
5 407,00 INR
Low
5 310,00 INR
Mkt. cap
626,12 млд
Avg. vol.
148,86 миң
Volume
99,57 миң
Dividend
1,00%
Quarterly dividend
13,25 INR
Ex-dividend date
2026-ж., 7-авг.
P/E ratio
29,43
52-wk high
5 933,50 INR
52-wk low
5 051,00 INR
EPS
180,45 INR
Shares outstanding
119,55 млн
No. of employees
19 миң
Open
5 407,00 INR
High
5 407,00 INR
Low
5 310,00 INR
Mkt. cap
626,12 млд
Avg. vol.
148,86 миң
Volume
99,57 миң
Dividend
1,00%
Quarterly dividend
13,25 INR
Ex-dividend date
2026-ж., 7-авг.
P/E ratio
29,43
52-wk high
5 933,50 INR
52-wk low
5 051,00 INR
EPS
180,45 INR
Shares outstanding
119,55 млн
No. of employees
19 миң
News stories
From web sources and news partners
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About Alkem Laboratories Ltd
CEO-
Employees19,3 миң
Founded1973
HeadquartersМамбай, Махараштра, Индия
SectorPharmaceutical industry
Last report
2026-ж., 14-авг.
Fiscal period
Q1 2027
EPS / Est. (INR)
43,49 INR / 47,04 INR
-7,56%miss
Revenue / Est. (INR)
37,40 млд / 37,96 млд
-1,46%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
40,01 млд
37,37 млд
36,03 млд
37,40 млд
Cost of goods sold
14,01 млд
12,73 млд
14,33 млд
12,01 млд
Cost of revenue
14,01 млд
12,73 млд
14,33 млд
12,01 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,10 млд
7,22 млд
17,12 млд
8,09 млд
Operating expense
17,73 млд
17,31 млд
17,80 млд
18,73 млд
Total operating expenses
31,74 млд
30,04 млд
32,13 млд
30,74 млд
Operating income
8,27 млд
7,33 млд
3,90 млд
6,66 млд
Other non operating income
1,04 млд
1,43 млд
-3,55 млд
1,53 млд
EBT including unusual items
8,95 млд
7,81 млд
4,22 млд
7,71 млд
EBT excluding unusual items
8,95 млд
8,33 млд
4,77 млд
7,71 млд
Income tax expense
1,16 млд
1,28 млд
1,71 млд
2,50 млд
Effective tax rate
12,98%
16,35%
40,53%
32,47%
Other operating expenses
9,69 млд
9,15 млд
-378,70 млн
9,64 млд
Net income
7,65 млд
6,36 млд
2,36 млд
5,20 млд
Net profit margin
19,12%
17,02%
6,56%
13,90%
Earnings per share
63,99
56,88
26,50
43,49
Interest and investment income
-
-
3,92 млд
-
Interest expense
-350,20 млн
-421,00 млн
-336,50 млн
-466,20 млн
Net interest expenses
-350,20 млн
-421,00 млн
3,58 млд
-466,20 млн
Depreciation and amortization charges
936,10 млн
950,10 млн
1,06 млд
1,00 млд
EBITDA
9,18 млд
8,11 млд
4,67 млд
7,43 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору